BofA Updates Managed Care Outlook, Raises Elevance Health (ELV) Price Target [Yahoo! Finance]
Elevance Health, Inc. (ELV)
Company Research
Source: Yahoo! Finance
BofA Updates Managed Care Outlook, Raises Elevance Health (ELV) Price Target On April 7, BofA lifted its price recommendation on Elevance Health, Inc. (NYSE:ELV) to $405 from $385. The firm kept a Neutral rating and lifted targets across several managed care names after CMS finalized Medicare Advantage rates for 2027. The analyst said the update provides clearer visibility on 2027 rates. The net increase of 2.48% came in above the high end of the 1% to 2% improvement the market had been expecting. During the Q4 2025 earnings call, CEO Gail Boudreaux said 2026 would be a year focused on execution and repositioning. She explained that guidance is based on practical and achievable assumptions, supported by pricing discipline, operational focus, and targeted investments. She also shared adjusted diluted earnings per share guidance of at least $25.50 for 2026, noting that 2025 results included about $3.75 per share in favorable nonrecurring items. Boudreaux also spoke about changes
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (ELV) had its price target lowered by Robert W. Baird from $340.00 to $317.00. They now have a "neutral" rating on the stock.MarketBeat
- ELV SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsGlobeNewswire
- Elevance Health (ELV) had its price target lowered by Truist Financial Corporation from $390.00 to $375.00. They now have a "buy" rating on the stock.MarketBeat
- Elevance Health (ELV) is now covered by Evercore Inc. They set an "in-line" rating and a $345.00 price target on the stock.MarketBeat
- Humana shares surge 12% on 2027 Medicare rate boost; UNH, CVS rally [Yahoo! Finance]Yahoo! Finance
ELV
Earnings
- 1/28/26 - Beat
ELV
Sec Filings
- 4/7/26 - Form PX14A6G
- 3/27/26 - Form DEF
- 3/27/26 - Form DEFA14A
- ELV's page on the SEC website